Barbexaclone

Barbexaclone

File:Barbexaclone.png
Clinical data
ATC code	N03AA04 (WHO)
Identifiers
IUPAC name (-)-N,α-Dimethylcyclohexaneethylammonium.5-ethyl-5-phenyl-barbiturate
CAS Number	4388-82-3
PubChem CID	71196
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C22H33N3O3
Molar mass	387.52 g/mol

Barbexaclone (marketed in Italy as Maliasin by Abbott Laboratories) is a salt compound of phenobarbital and propylhexedrine. It was introduced in 1983. It is reported to be as effective as phenobarbital but better tolerated. 100 mg of barbexaclone is equivalent to 60 mg of phenobarbital. It is not available on prescription in the UK or U.S.

References

• The Treatment of Epilepsy 2nd Ed by S. D. Shorvon (Editor), David R. Fish (Editor), Emilio Perucca (Editor), W. Edwin Dodson (Editor). Published by Blackwell 2004. ISBN 0-632-06046-8

Template:Pharma-stub de:Barbexaclon